Related Experiment Videos
White Matter Hyperintensities in Alzheimer's Disease: A Lesion Probability Mapping Study
Anna Damulina1, Lukas Pirpamer1, Stephan Seiler2
1Department of Neurology, Medical University of Graz, Graz, Austria.
Journal of Alzheimer'S Disease : JAD
|February 19, 2019
Summary
Alzheimer's disease patients show increased white matter hyperintensities (WMH) in periventricular brain regions compared to controls. However, WMH volume did not correlate with cognitive decline in this Alzheimer's disease study.
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- White matter hyperintensities (WMH) are common in Alzheimer's disease (AD).
- Previous studies indicate higher WMH load in AD patients across various brain regions.
- Spatial distribution differences of WMH between AD and controls require further investigation.
Purpose of the Study:
- To investigate spatial distribution differences of WMH between probable AD patients and age-matched healthy controls.
- To utilize lesion probability maps for detailed analysis of WMH distribution.
- To explore the relationship between WMH location and cognitive decline in AD.
Main Methods:
- Inclusion of 130 probable AD patients and 130 age-matched healthy controls.
- Assessment of cardiovascular risk factors (hypertension, diabetes, hypercholesterolemia, coronary artery disease, smoking).
- Non-linear registration of manually segmented FLAIR WMH masks to a template for voxel-based probability mapping.
Main Results:
- No significant differences in cardiovascular risk factors or overall WMH volume between AD patients and controls.
- AD patients exhibited a significantly higher likelihood of bilateral periventricular WMH compared to controls, even after adjustments.
- No significant association was found between periventricular WMH volume and cognitive decline in AD patients.
Conclusions:
- WMH in Alzheimer's disease are preferentially located in periventricular regions.
- The volume of white matter hyperintensities is unrelated to cognitive decline in AD patients, regardless of lesion location.